bioRxivBioinformaticsPreprint
BAMBI: Integrative biostatistical and artificial-intelligence method discover coding and non-coding RNA genes as biomarkers
Peng ZhouiD, Zixiu LiiD, Feifan LiuiD, Euijin Kwon, Tien‐Chan HsiehiD, Shangyuan YeiD, Shobha VasudevaniD, Jung-Ae LeeiD, Chan ZhouiD
Abstract
Accurate disease diagnosis and prognosis are crucial for effective treatment management and improving patient outcomes. However, accurately detecting early signs of certain diseases or recurrence remains challenging. Existing machine-learning methods for identifying gene expression biomarkers have several limitations, including poor performance on independent test datasets, inability to directly process omics data, and difficulty in identifying noncoding RNA genes as biomarkers. Additionally, these methods may not provide sufficient biological interpretation of their results, and the panel biomarkers they identify may not be suitable for clinical application. To address these limitations, we have developed a new computational method called BAMBI, which integrates multiple machine-learning algorithms and statistical approaches to identify putative coding and noncoding genes as biomarkers for disease diagnosis and prognosis. We evaluated BAMBI ability to identify diagnostic and prognostic biomarkers by analyzing multiple RNA-seq datasets from cancerous and non-cancerous diseases at population levels. The results from BAMBI demonstrate significant biological interpretability and state-of-the-art prediction performance. When the singular gene identified by BAMBI is used as a diagnostic biomarker, it achieves a balance accuracy exceeding 95% in studies of both breast cancer and psoriasis. Additionally, the prognostic biomarkers that BAMBI identifies from RNA-seq data of Acute Myeloid Leukemia (AML) patients significantly correlate with the survival rates in an independent AML patient cohort. Additionally, BAMBI outperforms existing methods by delivering more robust results, identifying biomarkers with fewer genes, and simultaneously achieving superior prediction accuracy. We have implemented BAMBI into user-friendly software for the research community. In summary, BAMBI serves as a more reliable pipeline for identifying both coding and noncoding genes as biosignature markers, enhancing the accuracy of disease diagnosis and prognosis. BAMBI is available via https://github.com/CZhouLab/BAMBI.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: benchmarking
- approach: machine learning (classical)
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- omicML: An Integrative Bioinformatics and Machine Learning Framework for Transcriptomic Biomarker Identification
Joy Prokash Debnath, Kabir Hossen, … Tanvir Hossain·bioRxiv·Oct 25, 2025
- blkbox: Integration Of Multiple Machine Learning Approaches To Identify Disease Biomarkers
Boris Guennewig, Zachary Davies, … Antony A. Cooper·bioRxiv·Apr 3, 2017
- LASSO Based Analysis for Prediction of Prognostic Signature Genes Associated with Breast Cancer
S. Guha·bioRxiv·Apr 2, 2024
- miRNA Biomarkers in Prostate Cancer: Leveraging Machine Learning for Improved Diagnostic Accuracy
Shweta Singh, Abhay Kumar Pathak, … Garima Jain·bioRxiv·Oct 25, 2024
- ECMarker: Interpretable machine learning model identifies gene expression biomarkers predicting clinical outcomes and reveals molecular mechanisms of human disease in early stages
Ting Jin, Nam D. Nguyen, … Daifeng Wang·BioinformaticsPeer-reviewed·Oct 22, 2020
- Benchmark of biomarker identification and prognostic modeling methods on diverse censored data
Wesley Fletcher, Samiran Sinha·PLoS ONEPeer-reviewed·Jun 16, 2026